You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國再生醫學(08158.HK):3290萬美元銷售基金權益
格隆匯 02-21 22:51

格隆匯2月21日丨中國再生醫學(08158.HK)公佈,於截至公告日期,CRML已向基金作出基金注資總額3500萬元。假設過往出售事項已完成,CRML作出的基金注資將減少至2975萬美元。根據投資條款,CRML須為基金的日常運營提供額外注資,而於截至公告日期,概無催繳或欠負任何金額。

於2020年2月21日,訂約方訂立進一步轉讓契據,據此CRML希望向熊千根轉讓而熊千根希望向CRML收購出售權益,連同作為B類有限合夥人於合夥協議項下的權利及責任,代價為3290萬美元(按匯率計算相當於2.57億港元)。

出售事項的所得款項現金淨額將約為2.25億港元。所得款項現金淨額用作以下用途:(i)約2640萬港元用於按等額基準進一步抵銷CRML及/或集團欠付及結欠熊千根的款項;(ii)約1950萬港元用於償還應付貿易賬款;(iii)約5050萬港元用於償還應計費用及其他應付賬項;(iv)約6250萬港元用於支付員工成本;(v)約550萬港元用於支付租金及收費;(vi)約1170萬港元用於支付水電費及其他開支;(vii)約1550萬港元用於支付專業費用及公司開支;及(viii)約3320萬港元用於支付廣告、營銷及推廣開支。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account